Menu
GWAS Study

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Hu L, Wu C, Zhao X et al.

22872573 PubMed ID
GWAS Study Type
1277 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HL
Hu L
WC
Wu C
ZX
Zhao X
HR
Heist R
SL
Su L
ZY
Zhao Y
HB
Han B
CS
Cao S
CM
Chu M
DJ
Dai J
DJ
Dong J
SY
Shu Y
XL
Xu L
CY
Chen Y
WY
Wang Y
LF
Lu F
JY
Jiang Y
YD
Yu D
CH
Chen H
TW
Tan W
MH
Ma H
CJ
Chen J
JG
Jin G
WT
Wu T
LD
Lu D
CD
Christiani DC
LD
Lin D
HZ
Hu Z
SH
Shen H
Chapter II

Abstract

Summary of the research findings

Purpose: Genetic variation may influence chemotherapy response and overall survival in cancer patients.

528 Han Chinese ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1277
Total Participants
GWAS
Study Type
Yes
Replicated
340 Han Chinese ancestry cases, 409 European ancestry cases
Replication Participants
East Asian, European
Ancestry
China, U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.